Summ ary: Since ionic Ca 2 + binds with intracellular cal modulin (CaM) before activating proteases, kinases, and phospholipases, demonstration of persistent Ca 2 + -CaM binding in neurons destined to show ischemic cellular in jury would support the concept that elevated intracellular Ca2+ plays a causative role in ischemic neuronal damage. In order to characterize Ca 2 + -CaM binding, we used a sheep anti-CaM antibody (CaM-Ab) which recognizes CaM that is not bound to Ca 2 + or brain target proteins. Therefore, immunohistochemical staining of brain sec tions by labeled CaM-Ab represented only unbound CaM. Six normal rats were compared to 15 animals ren dered ischemic for 30 min by a modification of the four vessel occlusion model. Animals were killed immediately after ischemia, and after 2 and 24 h of reperfusion. Brain sections through hippocampus were incubated in CaM Ab, and a diaminobenzadiene labeled anti-sheep second ary antibody was added to stain the CaM-Abo Staining in the endal limb of dentate, dorsal CAl, lateral CA3, and parietal cortex was graded on a 4-point scale. All normal
This study describes intraneuronal calcium calmodulin binding in a commonly used in vivo model of global cerebral ischemia. The project was undertaken for two reasons. It is now commonly accepted that calcium entry into neurons and re lease of stored intracellular calcium are pivotal events leading to irreversible cellular damage dur ing the reperfusion phase following an ischemic in sult. In the last several years many laboratories have demonstrated increased calcium in brain and in neurons after cerebral ischemia using a variety of animals had grade 4 staining indicating the presence of unbound CaM in all four brain regions, Ischemic animals demonstrated reduced (grade 0 to 2) staining in the CAl and CA3 regions immediately and 2 and 24 h after isch emia (p < 0.01 for both regions at all three time intervals) indicating persistent binding of CaM with Ca 2 + and target proteins in these regions. Staining decreased in dentate and cortex up to 2 h after ischemia (p = 0.02 for both regions) but returned toward normal by 24 h. We con clude that while most brain regions demonstrate in creased Ca 2 + -CaM binding immediately after ischemia, this binding returns to normal in brain regions destined to recover, such as cortex and dentate, but persists beyond 24 h in selectively vulnerable CA 1 and partially vulnera ble CA3, which are destined to undergo irreversible dam age. These findings support the hypothesis that calcium entry into neurons and consequent persistent activation of Ca 2 + -dependent enzyme systems leads to irreversible cell damage. Key Words: Calmodulin-Calcium Ischemia-Immunohistochemistry.
techniques (Hossman et al., 1983; Ouimet et al., 1984; Deshpande et al., 1987; Dux et ai., 1987; Ben veniste and Diemer, 1988; Martins et ai., 1988; Ue matsu et ai. , 1988) . However, none have conclu sively demonstrated that these changes in calcium trigger intraneuronal biochemical events before structural damage occurs, thereby playing a caus ative role in irreversible damage to selectively vul nerable neurons. Since ionic calcium binds prima rily with intracellular calmodulin before activating target enzymes, such as kinases, proteases, and phospholipases, demonstration of increased cal cium-calmodulin binding in neurons destined to show ischemic cellular injury would support the concept that elevated intracellular calcium acting through calmodulin may play a causative role in ischemic neuronal damage. Furthermore, therapeutic strategies for cellular protection after cerebral ischemia are presently di rected at preventing calcium flux into neurons. An assay of intracellular calcium monitored by calmod ulin binding could be used to assess the mechanism of action and efficiency of pharmacotherapy, such as dihydropyridine calcium channel blockers and N-methyl-D-aspartate (NMDA) receptor antago nists that are presently under evaluation in animal stroke models.
METHODS
The evaluation of calcium-calmodulin (CaM) binding in vivo required four separate stages: (a) quantification of CaM pre-and postischemia, (b) quantification of CaM target proteins available to CaM pre-and postischemia, (c) specification of a CaM antibody (CaM-Ab), and (d) immunohistochemical localization and quantitation of Ca 2 + -CaM binding using CaM-Abo Male Wi star rats weighing 220-280 g were used in all experiments. Ischemia was produced for 30 min by a modification of the four-vessel occlusion method (Grotta et al., 1988) . Animals were killed immediately after isch emia and after 2 and 24 h of reperfusion.
The CaM-Ab was produced by injecting purified CaM from rats testes into sheep three times at 2-week intervals (Dedman and Kaetzel, 1983; Dedman et aI., 1978) . The sheep were bled 2 weeks after the last injection. Serum was collected and affinity purified over a cyanogen bromide-activated Sepharose column that had been cou pled with CaM. This affinity purified CaM-Ab was used in all stages of this technique.
Quantification of CaM
This experiment was necessary to demonstrate whether or not CaM concentration changed after isch emia, since such changes might affect the amount of Ca2+ -CaM binding. Brain homogenates from two sets of normal, immediately postischemic, and 2-and 24-h post ischemic untreated rats were divided into two specimens. One was combined witl> EGT A and the other with Ca2 + . The two samples from each brain homogenate were ana lyzed by SDS-polyacrylamide gel electrophoresis (PAGE). The proteins were electroblotted onto nitrocel lulose paper and to prevent nonspecific binding of the antibody, the nitrocellulose paper was blocked with 3% bovine serum albumin (BSA) in 0.05% TWEEN 20 phos phate-buffered saline (TWEEN/PBS) for 1 h. The paper was washed in TWEEN/PBS, incubated with CaM-Ab diluted in TWEEN/PBS overnight at room temperature, and then washed three times with TWEEN/PBS for 30 min each time. Rabbit anti-sheep peroxidase-conjugated secondary antibody (Ab) (Orgon-Teknika) was then added at 1 :500 dilution and incubation for 1 h at room temperature. The paper was then washed in PBS for 30 min with three changes. Color development was done by reacting the paper with a solution containing PBS, 4chloro-l-naphthol, and H 2 0 2 . Water was used to stop the color reaction ( Fig. 1 ).
Quantification of CaM target proteins by calmodulin overlay
This experiment was necessary to demonstrate whether or not the quantity and quality of CaM binding to J Cereb Blood Flow Metab, Vol. 9, No. 6, 1989 target proteins changed after ischemia, since such changes might also affect the amount of Ca2+ -CaM bind ing. Brain homogenates from two sets of normal, imme diately postischemic, and 2-and 24-h postischemic, un treated rats were placed in a buffer containing 0.5 M Tris, glycerol, 10% sodium dodecyl sulfate (SDS}-2-mercap toethanol and bromophenol blue. SDS PAGE was per formed as described above using a 0.75-mm-thick gel. The gel was placed in a mild fixative of 40% methanol and 10% acetic acid for 30 min, then washed in 10% ethanol three times over 2 h. To allow brain proteins to renature partially, the gel was rinsed in H 2 0 and then washed in 100 mM imidazole and 1 mM CaCI 2 at 4°C for 30 min, then incubated in a buffer of 20 mM imidazole, 0.2 M KCI, 0.02% sodium azide, 1 mg/ml BSA, and 1 mM CaCI 2 for 30 min. Calmodulin labeled with Bolton-Hunter 1 2 51 (Du Pont NEN) was added to the gel to equal 106 cpm/lane and allowed to incubate overnight. The gel was washed in the above buffer without the BSA until the wash con tained only traces of radioactivity. The gel was rinsed in H 2 0 and stained in Coomassie brilliant blue in 40% meth anol and 10% acetic acid for 1-2 h, then destained in 40% methanol and 10% acetic acid and dried. The gel was placed in a cassette against Kodak XAR-5 film and ex posed for 8 to 12 h for autoradiography ( Fig. 2 ).
Specificity of CaM-Ab
This experiment was performed to determine if the CaM-Ab would distinguish between native unbound CaM and CaM bound to Ca2+ and target proteins. Calmodulin in PBS was dotted onto nitrocellulose paper using the Schleicher and Schue II dot blotting apparatus under a mild vacuum. The individual dots were cut out and blocked with BSA. The first set was combined with 1 mM EGT A, the second with 1 mM Ca 2 + , and the third with 1 mM Ca2+ plus brain homogenate. The dots were then incubated with CaM-Ab and processed by the method described above under Quantification of CaM (Fig. 3 ).
Localization of Ca 2 + -CaM binding using CaM-Ab
Brains were hand perfused and fixed with 4% paraformaldehyde in situ and then sliced by cryostat at -25°C. Sections of brain (40 f,lm) through hippocampus were placed into wells containing PBS. Our technique requires several transfers of the specimen, and in our hands, thinner sections resulted in tearing and loss of morphologic integrity. The PBS was drained, and 0.2% H 2 0 2 in PBS was added to block endogenous peroxi dases. After 30 min, the H 2 0 2 was removed, and the sec tions were washed twice in PBS and then incubated in Tris A (0.1 M Tris/saline, pH 7.6 containing 1% gelatin and 0.1 % Triton X-100) for 15 min. The Tris A was re moved and Tris B (Tris A plus I % rabbit serum) was added for 15 min. Tris B was removed and 1 ml of CaM Ab diluted in Tris B at 1: 100 was added to the sections. The sections were incubated on a shaker overnight at 4°C, and then washed in Tris A for 15 min, in Tris B for 15 min, and then incubated in rabbit anti-sheep peroxidase conjugated secondary Ab in Tris B diluted 1: 1 ,000 for 1 h at room temperature. The sections were then washed three times in 50 mM Tris/saline (pH 7.1) for 10 min, developed in diaminobenzidine diluted in 50 mM Tris/ saline (pH 7.1) for 10 min, and mounted on glass slides and examined by light microscopy. The ensure compara ble staining, sets of normal and postischemic brain sec tions to be compared were processed at the same time in exactly the same manner. The intensity of staining in the endal limb of dentate, dorsal CAl, lateral CA3, and layers I through VI of parietal cortex was graded on a 4 point scale (4 = extensive staining of neuronal soma; 3 = some staining of soma; 2 = some staining but soma not distin guishable; I = minimal staining; 0 = no staining) ( Fig. 4) . Five or six animals were studied in each of 4 groups (nor mal, and untreated ischemic immediately, 2, and 24 h after reperfusion). Statistical analysis was performed us ing the Kruskal-Wallis one-way analysis of variance (ANOV A) by rank.
RESULTS

Quantification of CaM
There was no change in the quantity of CaM at any time after ischemia compared to normals (Fig.  1) . All of the brains demonstrated the expected shift in molecular weight of CaM when bound with Ca 2 + . Therefore, any changes in Ca 2 + -CaM binding found after ischemia in immunohistochemical stud ies could not be due to changes in the amount of CaM present.
Quantification of CaM target proteins by calmodulin overlay
The CaM overlay gel was an autoradiographic demonstration of the concentration of target pro teins bound by CaM in brain homogenates of nor mal rats, immediately after ischemia, and after 2 and 24 h of reperfusion. By visual inspection there was no change in the quantity or quality of CaM target protein binding in any postischemic group compared to normals (Fig. 2) . Therefore, any changes in the amount of CaM target protein avail able could not be a major contributor to changes in Ca 2 + -CaM binding found after ischemia in immu nohistochemical studies.
Specificity of CaM-Ab
The antibody plus EGTA preparation had the greatest intensity of staining while preparations with Ca 2 + demonstrated less staining and Ca 2+ plus brain homogenate had no staining (Fig. 3) , estab lishing that when CaM is bound to target proteins it SPECIFICITY OF CaM ANTIBODY CaM EGT A + Antibody Ca++ + Antibody Brain Homogenate + Ca ++ + Antibody   FIG. 3 . CaM dots exposed to EGTA, Ca2+, or brain homogenate plus Ca2+, and then incubated with CaM-Ab and detected as described in Methods. Note that CaM-Ab does not recognize CaM bound to brain target protein plus Ca2+ .
is inaccessible to the CaM-Abo Therefore, in vivo immunohistochemical localization of CaM-Ab would correlate with the presence of CaM unbound to Ca2+ and target protein.
Localization of Ca 2 + -CaM binding using CaM-Ab
The brain sections were examined by light mi croscopy and graded as described in the Methods section (Table O . Normal animals had grade 4 stain- ing, indicating a preponderance of unbound CaM in all four brain regions examined (Figs. 4A and 5 ). All ischemic animals demonstrated loss of staining (grade 0--2) in the CAl and CA3 regions immedi ately and 2 and 24 h after ischemia (p < 0.01 for both regions at all three time intervals), indicating persistent binding of CaM with Ca2 + and target pro teins in these regions (Figs. 4B-E and 5). Staining decreased in the dentate and cortex up to 2 h after ischemia (p < 0.02 for both regions) but returned toward normal by 24 h (Fig. 5) . These changes cor relate with the distribution of morphologic damage recognizable by hematoxylin and eosin (H & E) staining on light microscopy in this model; CAl and the dorsal aspect of CA3 showing permanent dam age by 72 h but ventral CA3, dentate, and cortex demonstrating minimal damage (Pulsinelli et aI., 1982) . Ca2+ -CaM binding, however, clearly pre cedes morphologic changes that are not found in CAl and CA3 until after 24 h of reperfusion ( Fig.  4B-E ).
DISCUSSION
In this study, we have described a method for detecting Ca2 + -CaM binding applicable to in vivo stroke models. Interpretation of our results must be coupled with an understanding of the time course of light microscopic neuronal changes in this model. Previous studies (Grotta et aI., 1985 (Grotta et aI., , 1986 Pulsinelli et aI., 1982) have demonstrated minimal morpho logic abnormalities of CAl and CA3 neurons after up to 24 h of reperfusion following 20 or 30 min of ischemia. Most of CAl and the dorsal aspect of CA3 then progress to severe damage and even ne crosis by 72 h. We now describe that while most brain regions demonstrate increased Ca2 + -CaM binding immediately after ischemia, reflecting an in crease in intracellular calcium ion in neurons, this binding returns toward normal in brain regions des tined to recover, such as cortex and dentate, but persists beyond 24 h in hippocampal regions, such as the selectively vulnerable CA 1 and its partially c E vulnerable afferent connections (CA3), which are destined to undergo irreversible damage. These findings support the hypothesis that calcium entry into neurons and consequent activation of calcium dependent enzyme systems leads to irreversible cell damage.
Increased brain calcium after ischemia was first demonstrated by Rossmann et al. (1983) . Subse quent studies found that increased calcium in CAl was maximal after 48 h of reperfusion, suggesting . . that these changes might be a consequence and not the cause of cellular damage (Deshpande et aI., 1987; Dux et aI., 1987; Martins et aI., 1988) . Re cently, however, Benveniste and Diemer found in creased calcium after only 1 h of reperfusion in den tate (but not CAl ) (Benveniste and Diemer, 1988 (Dux et aI., 1987) . Furthermore, none of these studies directly measured the effect of cal cium on intracellular biochemical events. Our study identifies both a marker of increased intracellular calcium and of calcium activated enzymatic pro cesses.
Using a similar immunohistochemical technique, Ouimet et al. localized calcium-calmodulin-depen dent protein kinase II in hippocampi of normal rats J Cereb Blood Flow Metab, Vol. 9, No.6, 1989 (Ouimet et aI., 1984) . Protein kinase II was found in neuronal somata in the stratum pyramidale, and in dendrites in the strata radiatum and moleculare. Furthermore, protein kinase II was more prevalent in the endal than in the ectal limb of the dentate. Our findings show that the Ca2 + -CaM binding oc curs in exactly the same hippocampal regions, sug gesting that protein kinase II might be a target for the Ca2 + -CaM binding found in our studies.
One major limitation of our technique is that it is only semiquantitative, relying on the disappearance of brown pigmentation from normal brain regions as calcium binds with calmodulin. We are presently attempting to bind calmodulin with a radiolabeled antibody to allow more quantitative information.
In summary, we have demonstrated persistent binding of calmodulin by calcium in selectively vul nerable hippocampal neurons in an in vivo model of cerebral ischemia. This provides evidence that cal cium flux into neurons and/or release of stored in tracellular Ca 2 + during reperfusion after ischemia triggers intracellular biochemical events before structural damage occurs and therefore may play a causative role in the vulnerability of CA 1 and CA3 neurons.
